West European pharmaceutical companies are spending up to half a billion dollars a year on kickbacks for drug supplies to Russia, with an average of 30% of state procurement costs allocated for bonuses, which essentially fund a system of bribes rather than lowering drug prices for patients, as revealed by the investigative report by Project. #фармкомпании #госзакупки #взятки (translated)

